By 2045, more than half of the U.S. population is projected to be “other than non-Hispanic white.” Yet today, at least 83% of research participants are white even as they make up about 67% of the U.S. population while Hispanics represent 18% of the population but less than 1% of those enrolled in trials.
If the current clinical research process doesn’t adapt, the life sciences industry will continue leaving out the “other half.”
In this article, Sanskriti Thakur lays out the top three reasons why an inclusive, adaptive, decentralized model for research is the future offering the best path forward towards more health equity.
